Zobrazeno 1 - 10
of 44
pro vyhledávání: '"G C, Timmis"'
Publikováno v:
Journal of cardiac failure. 7(4)
Autor:
W W, O'Neill, P, Serruys, M, Knudtson, G A, van Es, G C, Timmis, C, van der Zwaan, J, Kleiman, J, Gong, E B, Roecker, R, Dreiling, J, Alexander, R, Anders
Publikováno v:
The New England journal of medicine. 342(18)
When administered intravenously at the time of percutaneous coronary revascularization, glycoprotein IIb/IIIa receptor antagonists decrease the incidence of death and nonfatal myocardial infarction and the need for urgent revascularization. We hypoth
Autor:
G C, Timmis, H D, White
Publikováno v:
The American journal of cardiology. 83(11)
Attempts to extract clot from an infarct-related coronary artery have underestimated the frequency and pathophysiologic significance of thrombus in acute coronary syndromes. The overwhelming body of evidence garnered over the last 20 years, especiall
Autor:
A M, Lincoff, J E, Tcheng, R M, Califf, D J, Kereiakes, T A, Kelly, G C, Timmis, N S, Kleiman, J E, Booth, C, Balog, C F, Cabot, K M, Anderson, H F, Weisman, E J, Topol
Publikováno v:
Circulation. 99(15)
Blockade of the platelet glycoprotein IIb/IIIa receptor with the monoclonal antibody fragment abciximab was shown in a placebo-controlled randomized trial to reduce the incidence of acute ischemic complications within 30 days among a broad spectrum o
Autor:
M A, Stevens, P A, McCullough, K J, Tobin, J P, Speck, D C, Westveer, D A, Guido-Allen, G C, Timmis, W W, O'Neill
Publikováno v:
Journal of the American College of Cardiology. 33(2)
This study was done to test the hypothesis that a forced diuresis with maintenance of intravascular volume after contrast exposure would reduce the rate of contrast-induced renal injury.We have previously shown a graded relationship with the degree o
Publikováno v:
Chest. 114(3)
Autor:
S, Ghaffari, D J, Kereiakes, A M, Lincoff, T A, Kelly, G C, Timmis, N S, Kleiman, J J, Ferguson, D P, Miller, R A, Califf, E J, Topol
Publikováno v:
The American journal of cardiology. 82(1)
We determined the efficacy of abciximab, a platelet glycoprotein IIb/IIIa receptor antagonist, combined with low-dose weight-adjusted heparin in reducing ischemic complications in patients undergoing directional coronary atherectomy (DCA). The Evalua
Autor:
J S, Mandak, J C, Blankenship, L H, Gardner, S D, Berkowitz, F V, Aguirre, K N, Sigmon, G C, Timmis, I C, Gilchrist, M, McIvor, J, Resar, B H, Weiner, B S, George, J D, Talley, A M, Lincoff, J E, Tcheng, R M, Califf, E J, Topol
Publikováno v:
Journal of the American College of Cardiology. 31(7)
This study was designed to identify potential predictors of vascular access site (VAS) complications in the large-scale Integrilin to Minimize Platelet Aggregation and Coronary Thrombosis (IMPACT) II trial, which studied angioplasty with versus witho
Publikováno v:
Chest. 112(4)
Publikováno v:
Chest. 109(3)
Measuring maximal handgrip strength at the time of hospital discharge provides a simple method for prescribing load holding and load carrying and patients who have had myocardial infarction.